A
Arvinas, Inc.
ARVN · NASDAQ · Healthcare · 579M
Price · close
$9.37
+3.77% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.4×
Enterprise value / EBITDAEV/EBITDA
-6.3×
Free cash flow yieldFCF yield
-45.4%
Return on equityROE
-18.6%
Operating margin
-43.8%
Net debt / EBITDAbalance-sheet strength
1.8×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.